ROKIT Healthcare (KOSDAQ 376900, CEO Seokhwan You), a specialist in AI-driven hyper-personalized organ regeneration platforms, announced that it has been selected as a 2025 Excellent Technology Company by the Global Digital Innovation Network (GDIN).

GDIN, an organization under the Ministry of Science and ICT, supports the global expansion of promising Korean digital technology companies. Through this award, Rokit Healthcare has once again been recognized for its unrivaled innovation and global commercialization capabilities in AI organ regeneration, following its previous recognition in 2023.

This year, ROKIT Healthcare achieved remarkable results in skin cancer, cartilage, and kidney regeneration, building on the successful commercialization of its diabetic foot ulcer (DFU) treatment. Notably, by obtaining a core patent for kidney regeneration technology in Japan, the company has established a foothold in one of the world's top three kidney failure markets. It also successfully secured Proof of Concept (PoC) and regulatory approvals for its AI-driven platform in major global markets, including the U.S. and Europe.

"Our AI-driven hyper-personalized organ regeneration platform has already entered over 40 countries. By achieving a turnaround to profitability in the third quarter, we have proven the marketability of our technology," said an official from ROKIT Healthcare. "Based on the high cure rates seen in diabetic foot treatment, we are accelerating global clinical trials and insurance reimbursement for our cartilage and kidney regeneration pipelines."

CEO Seokhwan You expressed his vision during the ceremony, stating, "Being named a GDIN Excellent Company for 2025 acknowledges that ROKIT Healthcare is more than just a developer—it is a 'first mover' creating real-world global revenue models. We will continue to solidify our global leadership in organ regeneration platforms that substantially extend healthy human lifespan. Our goal is to standardize AI-driven hyper-personalized technology for the 4 billion chronic disease patients worldwide."